CGEM vs KR · $830.3M cap vs P/E 19, rev $147.12B
Cullinan Oncology LLC (CGEM) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Kroger Company (KR) is a grocery stores company listed on US.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
CGEM currently screens at market cap $830.3M. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the CGEM and KR stock pages for the full models.
Not investment advice.